Skip to main content
. 2020 Nov 11;21(22):8471. doi: 10.3390/ijms21228471
ADC Antibody drug conjugate
ATP Adenosine triphosphate
BBB Blood brain barrier
BiTE Bispecific T-cell engager
CDK Cyclin-dependent kinase
CNS Central nervous system
CSF Cerebrospinal fluid
CYP Cytochrome P450
ecDNA Extrachromosomal DNA
EGF Epidermal growth factor
EGFR Epidermal growth factor receptor
EIAED Enzyme inducing antiepileptic drug
EORTC European Organization for Research and Treatment of Cancer
ErbB Erb-b2 receptor tyrosine kinase
FISH Fluorescence in situ hybridization
GBM Glioblastoma
Grb2 Growth factor receptor-bound protein 2
HB-EGF Heparin-binding EGF-like growth factor
HER Human epidermal growth factor receptor
IC50 Half maximal inhibitory concentration
IGFR1 Insulin growth factor receptor 1
IHC Immunohistochemistry
INSIGhT Individualized Screening Trial of Innovative Glioblastoma Therapy clinical trial
JAK Janus kinase
KLH Keyhole limpet hemocyanin
KRAS Kirsten rat sarcoma
MAPK Mitogen-activated protein kinase
MET MET receptor tyrosine kinase; also known as hepatocyte growth factor receptor
MGMT Enzyme O6-methylguanine-DNA methyltransferase
MMAF Monomethyl auristatin F
MRI Magnetic resonance imaging
NABTC North American Brain Tumor Consortium
NCCTG North Central Cancer Treatment Group
NSCLC Non-small cell lung cancer
OS Overall survival
PDB Protein Database
PI3K Phosphoinositide-3 kinase
PFS Progression free survival
PKB Protein kinase B; also known as Akt
PKC Protein kinase C
PLCγ Phospholipase C γ
RET Rearranged during transfection
RT Radiotherapy
RTOG Radiation Therapy Oncology Group
SPECT Single-photon emission computed tomography
STAT Signal transducer and activator of transcription
TGF-α Transforming growth factor-α
TKI Tyrosine kinase inhibitor
TMZ Temozolomide